Clinical trial Recruiting at 1 site Observational Ages 2 and up

EXOPULSE database for routine follow-up of balance, muscle function, and chronic pain

Official title: The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes

Run by Otto Bock Healthcare Products GmbH · NCT05901259 · Data updated 2026-11-12

This registry will try the EXOPULSE Mollii and EXOPULSE suits to see if they improve balance, muscle relaxation, local circulation, and chronic pain for people with cerebral palsy, multiple sclerosis, stroke, fibromyalgia, or other neurologic conditions.

Quick facts

Study typeObservational
Ages2 Years and up
SexAll
Enrollment200 (estimated)
SponsorOtto Bock Healthcare Products GmbH
Industry-sponsored
Locations1 site (Bergshamra, Stockholm County)
StatusRecruiting
StartedFebruary 18, 2026
Main results expectedAugust 1, 2027
Study endsDecember 31, 2027
Registry record updatedSeptember 14, 2026
Trial IDNCT05901259 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 2 years or older with cerebral palsy, multiple sclerosis (diagnosed >6 months), stroke (diagnosed >6 months), fibromyalgia (diagnosed >1 month), or other neurologic disorders causing similar symptoms, who can give informed consent and follow instructions and who meet the device size and safety criteria.

Probably not a fit

Patients with device contraindications, recent botulinum toxin treatment (<3 months), recent medication changes affecting neuromuscular activity, extreme body sizes outside the device limits, or inability to attend on-site assessments are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational registry collecting standardized clinical data before, during, and after use of the EXOPULSE Mollii Suit and EXOPULSE Suit in people with CP, MS, stroke, fibromyalgia and related neurologic disorders. Participants serve as their own controls and the primary outcome is change in the Berg Balance Scale or Pediatric Balance Scale, with additional measures of muscle activation, relaxation, local blood flow, and chronic pain. Investigators are trained and certified in the EXOPULSE method and apply standardized stimulation settings based on age and impairment to reduce variability; assessments are unblinded because the stimulation is usually perceptible. Routine re-assessments are conducted at scheduled visits by multiple investigators to help identify high responders within diagnostic subgroups.

Why it matters

Potential benefit: If successful, the suits could reduce muscle stiffness and chronic pain, improve balance, and lower fall risk, leading to better daily function.

How similar studies have gone: Smaller case series and pilot studies of Mollii-style wearable electrical stimulation have reported improvements in spasticity, pain, and function, but robust randomized evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with CP, MS, stroke, fibromyalgia or other neurologic disorder that may cause such type of symptoms.
* Diagnosed \>6 months prior to inclusion in case of MS or stroke as well as \>1 month prior to inclusion in the case of fibromyalgia.
* Give written informed consent
* Cognitively able to understand and follow verbal and/or written instructions
* A minimum age of 2 years

Exclusion Criteria:

* Any of the contraindications listed in the instructions for use of the EXOPULSE Mollii Suit or EXOPULSE Suit
* Being introduced to any new medication affecting the neuromuscular activity during the study period
* Using botulinum toxin \<3 month before or during the study period
* Subjects \<100 cm and \<13 kg
* Subjects \>205 cm and \>115 kg

Where it's running

  • Ottobock Care Sverige
    Bergshamra, Stockholm County, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.